Have a personal or library account? Click to login
Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients Cover

Humoral response after breakthrough SARS-CoV-2 infection in type 2 diabetes mellitus patients

Current Issues in Pharmacy and Medical Sciences
Volume 36 (2023): Issue 4 (December 2023)
By: Aleksander Michalski,  Magdalena Goralczyk,  Michal Brzozowski,  Jakub Dworzanski,  Bartlomiej Drop,  Ewa Stepien and  Malgorzata Polz-Dacewicz  
Open Access
|Dec 2023

Authors

Aleksander Michalski

Poland

Magdalena Goralczyk

Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, Poland

Michal Brzozowski

Poland

Jakub Dworzanski

Masovian Specialist Hospital, Radom, Poland

Bartlomiej Drop

Department of Computer Science and Medical Statistics with the e-Health Laboratory, Lublin, Poland

Ewa Stepien

ewa.stepien@umlub.pl

Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, Poland

Malgorzata Polz-Dacewicz

Department of Virology with Viral Diagnostics Laboratory, Medical University of Lublin, Poland
DOI: https://doi.org/10.2478/cipms-2023-0038 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Journal RSS Feed
Language: English
Page range: 221 - 226
Submitted on: Jul 6, 2023
|
Accepted on: Nov 15, 2023
|
Published on: Dec 25, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
SARS-CoV-2 antibody,
diabetes,
NCP,
RBD,
S2,
vaccination
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Pharmacology, toxicology,
Pharmacy,
Pharmacy, other

© 2023 Aleksander Michalski, Magdalena Goralczyk, Michal Brzozowski, Jakub Dworzanski, Bartlomiej Drop, Ewa Stepien, Malgorzata Polz-Dacewicz, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 36 (2023): Issue 4 (December 2023)Next article